Federal award (BPA CALL, fiscal year 2022)
Recipient: BOOZ ALLEN HAMILTON INC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2019-01-08 to 2023-09-27
Current total value of award: $5647363.84
Description: THIS CONTRACT WILL INVOLVE DEVELOPING A LANDSCAPE ASSESSMENT OF EVIDENTIARY STANDARDS AND DEVELOPING EVIDENTIARY STANDARDS FOR THE USE OF PHARMACODYNAMIC BIOMARKERS FOR BIOSIMILAR DRUG DEVELOPMENT.